ENTERAL NUTRITION MARKET ANALYSIS

Enteral Nutrition Market, By Product Type (Standard Enteral Nutrition and Enteral Nutrition for Chronic Illness), By Nutrition Type (Proteins, Carbohydrates, Multi-vitamins and Antioxidants, Amino Acid, Fibers, Minerals, and Others), By Formulation (Powder and Liquid), By Patient Type (Adult, Pediatrics, and Geriatrics), By Application (Cancer, Gastrointestinal Diseases, Diabetes, Critical Care, and Others (Nutrition Deficiency, etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), By End User (Hospitals, Home Care Settings, Retirement Homes, Others (Nursing Care Centers, Rehabilitation Care Centers, etc.)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Published In : Sep 2023
Code : CMI1115
Pages :200
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Enteral Nutrition Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global enteral nutrition market over the forecast period. North America is estimated to hold 33.5% of the market share in 2023, and this is attributed to the presence of major players such as Abbott, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, and others, which contribute to the development of the enteral nutrition market in North America.

Global Enteral Nutrition Market - Key Players

Major players operating in the global enteral nutrition market include Abbott, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., and Curtis Health Caps SP.